| THE
TECHNOLOGY
Upstream has filed seven (7) provisional patents and has a proprietary
discovery pipeline that the Company would like to see generate a stream
of intellectual property.
1. Drug Response Diagnostics
A novel test for predicting the impact of genetic variations
on patient drug reaction.
2. Liver Cancer Susceptibility Test
Genetic variations that determine a patients’ risk of
getting liver cancer.
3. Prostate Cancer Susceptibility Test
Genetic variations that determine a patients’ risk of
getting prostate cancer.
4. Ovarian Cancer Susceptibility Test
Genetic variations that determine a patients’ risk of
getting ovarian cancer.
5. Thyroid Cancer Susceptibility Test
Genetic variations that determine a patients’ risk of
getting thyroid cancer.
6. Method for combining 3D quantitative
chemical structure activity relationships of compounds with genetic
variation of drug targets and metabolic enzymes to optimize efficacy,
provide predictive toxicology, and address drug resistant microorganisms.
7. Anti-parasitic compounds and methods
for selection thereof.
|
